Published in Biomed Res Int on January 22, 2015
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol (2003) 7.54
Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol (1999) 2.19
Saliva: an emerging biofluid for early detection of diseases. Am J Dent (2009) 1.91
The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol (1999) 1.65
Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol (1999) 1.52
Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann N Y Acad Sci (2007) 1.41
Scoring systems in pemphigus. Indian J Dermatol (2011) 1.11
Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol (2000) 1.11
Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol (2002) 1.07
Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis. Autoimmun Rev (2012) 1.04
Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol (2010) 1.00
Saliva--a diagnostic window to the body, both in health and in disease. J Med Life (2010) 0.99
Current development of saliva/oral fluid-based diagnostics. Tex Dent J (2010) 0.98
Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission. J Eur Acad Dermatol Venereol (2008) 0.91
Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris. Iran J Allergy Asthma Immunol (2009) 0.85
An insight into salivary markers in oral cancer. Dent Res J (Isfahan) (2013) 0.84
Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. J Eur Acad Dermatol Venereol (2009) 0.83
Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol (2003) 0.82
Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris. J Eur Acad Dermatol Venereol (2011) 0.80
Determination of salivary and serum immunoglobulin concentrations in the cat. Vet Immunol Immunopathol (1998) 0.79
Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. J Eur Acad Dermatol Venereol (2007) 0.79
Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study. Eur J Dermatol (2013) 0.78
Pemphigus treatment in Japan. Dermatol Clin (2011) 0.77
Reactivation of cutaneous leishmaniasis after renal transplantation: a case report. Case Rep Dermatol Med (2014) 0.77